GO:0043456 regulation of pentose-phosphate shunt: Metabolic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043456 (regulation of pentose-phosphate shunt) describes any process that modulates the frequency, rate or extent of the pentose-phosphate shunt, the glucose-oxidizing pathway coupled to NADPH synthesis.
• The pentose-phosphate shunt is a major source of NADPH and ribose-5-phosphate, supporting reductive biosynthesis and nucleotide production.
• Its regulation is critical in cancer, where enhanced flux supports proliferation and chemoresistance.
• Key regulatory nodes include G6PD, 6PGD, transketolase, transaldolase, and upstream signals such as NRF2 and POU2F1-ALDOA.
• Emerging layers of control include lactylation of DCBLD1, glycogen compartmentalization, and myomiR regulation in muscle hypertrophy.
• Studying this process benefits from CRISPR knockout, point-mutation, knock-in, and overexpression models combined with metabolic and transcriptomic profiling.
Description
The pentose-phosphate shunt, also called the pentose-phosphate pathway, is a cytosolic route that oxidizes glucose to generate NADPH and ribose-5-phosphate, which are essential for reductive biosynthesis and nucleotide synthesis. The Gene Ontology term GO:0043456, regulation of pentose-phosphate shunt, captures any process that modulates the frequency, rate or extent of this pathway. Because the shunt sits at the intersection of glucose metabolism, redox balance, and biosynthetic demand, its regulation is central to how cells adapt to growth, stress, and immune activation. Researchers study this term to understand how metabolic flux is rewired in cancer, cardiac disease, and immune memory, and to identify targets for therapeutic intervention. The pathway is not a fixed module; it is dynamically controlled by transcriptional, post-translational, and allosteric mechanisms that tune NADPH output and ribose supply. Consequently, GO:0043456 is a high-value annotation for functional genomics, metabolic engineering, and disease modeling.
regulation of pentose-phosphate shunt At A Glance
| GO ID | GO:0043456 |
|---|---|
| GO term | regulation of pentose-phosphate shunt |
| Ontology | biological_process |
| Synonym | regulation of pentose phosphate pathway; regulation of pentose-phosphate pathway; regulation of pentose phosphate shunt |
| Major function | Modulates the rate of glucose oxidation coupled to NADPH synthesis |
| Pathway branches | Oxidative branch (G6PD, 6PGD) and non-oxidative branch (transketolase, transaldolase) |
| Key outputs | NADPH for reductive biosynthesis and ribose-5-phosphate for nucleotides |
| Regulatory layers | Transcriptional, post-translational, allosteric, and metabolic compartmentalization |
| Disease relevance | Cancer, cardiac dysfunction, immune memory, and muscle hypertrophy |
What Is GO:0043456?
GO:0043456 is a biological_process term defined as any process that modulates the frequency, rate or extent of the pentose-phosphate shunt, the process in which glucose is oxidized, coupled to NADPH synthesis. In other words, it covers the regulatory inputs that adjust how much glucose flows through the oxidative and non-oxidative branches of the pathway, thereby controlling NADPH and ribose-5-phosphate availability.
Why Is regulation of pentose-phosphate shunt Important in Cell Biology?
Regulation of the pentose-phosphate shunt is important because it determines the balance between NADPH production and ribose-5-phosphate supply, which in turn influences cell survival, proliferation, and redox defense. Dysregulated shunt activity is a hallmark of many cancers, where it supports anabolic growth and chemoresistance. In the heart, activation of the pathway can reduce cardiac dysfunction, while in immune cells it supports memory formation. Thus, understanding GO:0043456 provides mechanistic insight into metabolic control and identifies candidate targets for therapeutic modulation.
• Supports cancer cell proliferation by supplying ribose-5-phosphate for nucleotide synthesis.
• Provides NADPH to maintain redox homeostasis and support reductive biosynthesis.
• Contributes to chemoresistance in colon cancer through the POU2F1-ALDOA axis.
• Is linked to cervical cancer progression via lactylation-stabilized DCBLD1.
• Plays a role in cardiac protection through NRF2-mediated metabolic reprogramming.
• Regulates CD8+ memory T cell metabolism via glycogen compartmentalization.
• Is modulated during mechanical load-induced muscle hypertrophy by myomiRs.
• Represents a metabolic vulnerability that can be targeted with CRISPR screens.
• Serves as a biomarker of metabolic reprogramming in multiple diseases.
• Enables functional annotation of metabolic genes in genome-scale studies.
What Happens During regulation of pentose-phosphate shunt?
Oxidative branch and NADPH production
In simple terms: The first part of the shunt uses glucose to make NADPH, a molecule that helps cells fight stress and build molecules.
The oxidative branch of the pentose-phosphate shunt begins with glucose-6-phosphate dehydrogenase (G6PD), which converts glucose-6-phosphate to 6-phosphogluconolactone while reducing NADP+ to NADPH. Subsequent steps catalyzed by 6-phosphogluconolactonase and 6-phosphogluconate dehydrogenase (6PGD) generate ribulose-5-phosphate and additional NADPH. Regulation of this branch controls the rate of NADPH synthesis, which is essential for reductive biosynthesis and antioxidant defense.
Non-oxidative branch and ribose-5-phosphate supply
In simple terms: The second part rearranges sugars to produce ribose-5-phosphate, the building block for DNA and RNA.
The non-oxidative branch interconverts ribulose-5-phosphate, ribose-5-phosphate, xylulose-5-phosphate, and glycolytic intermediates through transketolase and transaldolase. This branch is reversible and allows the shunt to adapt to cellular demands for ribose-5-phosphate or glycolytic flux. Regulation of these enzymes modulates the balance between nucleotide synthesis and glycolysis.
Allosteric and post-translational control
In simple terms: Enzymes in the shunt can be switched on or off by small molecules or chemical modifications.
The pentose-phosphate shunt is regulated by allosteric effectors such as NADP+/NADPH ratios and by post-translational modifications including lactylation. For example, lactylation stabilizes DCBLD1, which activates the pathway in cervical cancer. Such modifications provide rapid, reversible control of flux in response to metabolic state.
Transcriptional and signaling regulation
In simple terms: Cells can make more or fewer shunt enzymes by turning genes on or off through signaling pathways.
Transcriptional regulators such as NRF2 induce expression of pentose-phosphate shunt genes, leading to metabolic reprogramming in the heart. The POU2F1-ALDOA axis enhances glycolysis and shunt activity in colon cancer cells. These signaling circuits integrate growth factor, stress, and oncogenic signals to adjust pathway capacity.
Compartmentalization and metabolic coupling
In simple terms: The shunt can be physically grouped with other metabolic processes inside cells to work more efficiently.
In CD8+ memory T cells, glucose-1-phosphate promotes compartmentalization of glycogen with the pentose-phosphate shunt, enabling efficient NADPH production. This spatial organization represents a layer of regulation that couples glycogen metabolism to shunt activity. Such compartmentalization is an emerging theme in metabolic regulation.
Key Genes Involved in GO:0043456 regulation of pentose-phosphate shunt
The following genes and proteins are central to the regulation of the pentose-phosphate shunt, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| G6PD | Rate-limiting enzyme of oxidative branch; produces NADPH | Target for metabolic and redox studies; knockout models available |
| 6PGD | Oxidative decarboxylation; produces NADPH and ribulose-5-phosphate | Linked to cancer metabolism and chemoresistance |
| TKT | Transketolase; non-oxidative branch interconversion | Modulates ribose-5-phosphate supply; target in cancer |
| TALDO1 | Transaldolase; non-oxidative branch | Involved in metabolic balance; disease associations |
| RPIA | Ribose-5-phosphate isomerase; ribose-5-phosphate production | Supports nucleotide synthesis; potential cancer target |
| RPE | Ribulose-5-phosphate epimerase; xylulose-5-phosphate production | Regulates non-oxidative flux |
| ALDOA | Glycolytic enzyme; part of POU2F1-ALDOA axis | Promotes proliferation and chemoresistance in colon cancer |
| DCBLD1 | Lactylation-stabilized protein activating shunt | Promotes cervical cancer progression |
| NRF2 | Transcription factor inducing shunt genes | Cardiac metabolic reprogramming and protection |
| POU2F1 | Transcription factor upregulating ALDOA | Oncogenic regulation of glycolysis and shunt |
| PFKM | Glycolytic enzyme; affects shunt flux | Metabolic engineering target |
| PKM | Pyruvate kinase; links glycolysis and shunt | Cancer metabolism studies |
| GPI | Glucose-6-phosphate isomerase; glycolysis-shunt balance | Functional annotation in metabolic screens |
| H6PD | Hexose-6-phosphate dehydrogenase; NADPH production in ER | Endoplasmic reticulum redox regulation |
| MYOMIRs | MicroRNAs regulating shunt during hypertrophy | Muscle growth and metabolic regulation |
| GLYCOGEN | Glycogen compartmentalization with shunt | CD8+ memory T cell metabolism |
How Is regulation of pentose-phosphate shunt Regulated?
Regulation of the pentose-phosphate shunt occurs at multiple levels. Allosteric control by NADP+/NADPH ratios adjusts enzyme activity in real time. Post-translational modifications such as lactylation stabilize DCBLD1 and activate the pathway. Transcriptional regulation by NRF2 induces shunt gene expression in the heart, while the POU2F1-ALDOA axis enhances both glycolysis and shunt activity in colon cancer. Additionally, myomiRs modulate the pathway during mechanical load-induced hypertrophy, and glycogen compartmentalization provides spatial regulation in CD8+ memory T cells. These mechanisms collectively tune NADPH and ribose-5-phosphate production to meet cellular demands.
regulation of pentose-phosphate shunt and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| G6PD | Cancer metabolism and redox balance | Knockout and overexpression cell lines |
| DCBLD1 | Cervical cancer progression | Point-mutation and knock-in models |
| ALDOA | Colon cancer chemoresistance | Knockout and overexpression models |
| NRF2 | Cardiac dysfunction | Knock-in and knockout mouse models |
| TKT | Cancer proliferation | CRISPR knockout in cancer cell lines |
Cancer
The pentose-phosphate shunt is frequently upregulated in cancer to support proliferation and survival. In colon cancer, the POU2F1-ALDOA axis promotes chemoresistance by enhancing glycolysis and shunt activity. In cervical cancer, lactylation-stabilized DCBLD1 activates the pathway to drive progression. Targeting shunt regulation is therefore a potential therapeutic strategy.
Cardiac dysfunction
NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose-phosphate shunt. This suggests that modulating shunt activity can be cardioprotective.
Immune memory and muscle hypertrophy
In CD8+ memory T cells, glycogen compartmentalization with the shunt supports memory formation. In skeletal muscle, myomiRs regulate the shunt during mechanical load-induced hypertrophy. These findings link shunt regulation to immune and muscle physiology.
From regulation of pentose-phosphate shunt-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of G6PD affect shunt flux and NADPH levels? | G6PD knockout cell line |
| Does a specific point mutation in DCBLD1 alter lactylation and pathway activation? | Point-mutation knock-in |
| Can NRF2 overexpression protect against cardiac dysfunction? | Overexpression and knock-in models |
| How does ALDOA knockout affect chemoresistance in colon cancer? | Knockout cell line |
| Does glycogen compartmentalization require specific enzymes? | Tagged knock-in and knockout models |
| What is the role of myomiRs in shunt regulation during hypertrophy? | Overexpression and knockout in muscle cells |
How to Study the regulation of pentose-phosphate shunt Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Carbon flow through shunt branches | Quantifying pathway activity |
| RNA-seq | Transcript levels of shunt genes | Identifying transcriptional regulation |
| Proteomics | Protein abundance and modifications | Detecting post-translational changes |
| CRISPR knockout screens | Gene essentiality for shunt activity | Discovering novel regulators |
| NADPH/NADP+ assays | Redox ratio | Measuring oxidative branch output |
| Ribose-5-phosphate quantification | Non-oxidative branch output | Assessing nucleotide synthesis capacity |
| Tagged knock-in imaging | Subcellular localization | Studying compartmentalization |
| Lactylation immunoblotting | Protein lactylation status | Investigating post-translational regulation |
Metabolic flux analysis
Metabolic flux analysis using 13C-labeled glucose can quantify carbon flow through the oxidative and non-oxidative branches of the shunt. This method is essential for measuring the impact of regulatory perturbations.
Transcriptomics and proteomics
RNA-seq and proteomics can identify changes in shunt gene expression and protein abundance upon regulatory signals. These approaches reveal transcriptional and post-transcriptional control mechanisms.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes that regulate shunt activity and NADPH production. Such screens are powerful for discovering novel regulators.
Imaging and compartmentalization studies
Fluorescence imaging and tagged knock-in models can visualize spatial organization of shunt enzymes with glycogen or other compartments. This reveals subcellular regulation.
How CRISPR Can Be Used to Study GO:0043456 regulation of pentose-phosphate shunt
Knockout
CRISPR knockout of shunt genes such as G6PD, TKT, or ALDOA can reveal their requirement for NADPH production and cell proliferation. Knockout models are essential for causal inference in metabolic studies.
Point Mutation
Point mutations can be introduced to mimic or abrogate post-translational modifications, such as lactylation sites on DCBLD1. This allows precise testing of regulatory mechanisms.
Knock-in
Knock-in of tagged versions of shunt enzymes enables visualization and interaction studies. It can also be used to express mutant alleles under endogenous regulation.
Overexpression
Overexpression of NRF2 or ALDOA can enhance shunt activity and model disease states such as cardiac protection or chemoresistance. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of pentose-phosphate shunt Research
Researchers studying regulation of pentose-phosphate shunt-related genes often need to determine whether a candidate gene is causally involved in pathway control, NADPH production, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of pentose-phosphate shunt research.
Frequently Asked Questions About regulation of pentose-phosphate shunt
What is GO:0043456?
GO:0043456 is the Gene Ontology term for regulation of pentose-phosphate shunt, describing any process that modulates the rate of glucose oxidation coupled to NADPH synthesis.
What genes are involved in regulation of pentose-phosphate shunt?
Key genes include G6PD, 6PGD, TKT, TALDO1, ALDOA, DCBLD1, and NRF2, among others.
Why is the pentose-phosphate shunt important in cancer?
It supplies ribose-5-phosphate and NADPH to support proliferation and chemoresistance.
How is the pentose-phosphate shunt regulated?
It is regulated by allosteric effectors, post-translational modifications, transcriptional programs, and compartmentalization.
What is the role of NRF2 in the pentose-phosphate shunt?
NRF2 induces shunt gene expression and protects against cardiac dysfunction.
How does lactylation affect the pentose-phosphate shunt?
Lactylation stabilizes DCBLD1, which activates the pathway in cervical cancer.
What experimental models are used to study shunt regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models are commonly used.
What methods measure pentose-phosphate shunt activity?
13C metabolic flux analysis, NADPH assays, and ribose-5-phosphate quantification are standard.
Is the pentose-phosphate shunt involved in immune memory?
Yes, glycogen compartmentalization with the shunt supports CD8+ memory T cell formation.
Can the pentose-phosphate shunt be targeted therapeutically?
Yes, targeting shunt regulators is a potential strategy in cancer and cardiac disease.
Conclusion
GO:0043456, regulation of pentose-phosphate shunt, is a critical biological process that controls NADPH and ribose-5-phosphate production. Its dysregulation is implicated in cancer, cardiac dysfunction, and immune memory, making it a rich area for functional genomics and therapeutic development. CRISPR-based models and metabolic profiling are powerful tools to dissect its regulatory mechanisms.
References
- 1. Stincone A et al.. 2015. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.. Biol Rev Camb Philos Soc 90(3):927-63 PMID: 25243985
- 2. Patra KC et al.. 2014. The pentose phosphate pathway and cancer.. Trends Biochem Sci 39(8):347-54 PMID: 25037503
- 3. Zhou Y et al.. 2025. Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8(+) memory T cells.. Mol Cell 85(13):2535-2549.e10 PMID: 40499549
- 4. Meng Q et al.. 2024. Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.. J Exp Clin Cancer Res 43(1):36 PMID: 38291438
- 5. Ramos-Martinez JI. 2017. The regulation of the pentose phosphate pathway: Remember Krebs.. Arch Biochem Biophys 614:50-52 PMID: 28041936
- 6. Lin J et al.. 2022. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.. Oncogene 41(7):1024-1039 PMID: 34997215
- 7. Valentino T et al.. 2021. Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load-induced hypertrophy.. Physiol Rep 9(23):e15137 PMID: 34889054
- 8. Zoccarato A et al.. 2025. NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway.. Cardiovasc Res 121(2):339-352 PMID: 39657243
